The story of Viagra, initially marketed by copyright, presents a intricate case study for stakeholders considering the healthcare sector. While its groundbreaking success and generation of vast in revenue , the intellectual property end has opened the way for generic medications, substantially eroding income potential . This shift raises concerns a